Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$13.6 - $17.88 $510,000 - $670,500
-37,500 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$16.0 - $20.59 $120,000 - $154,425
7,500 Added 25.0%
37,500 $614,000
Q1 2021

May 17, 2021

SELL
$19.16 - $28.09 $19,160 - $28,090
-1,000 Reduced 3.23%
30,000 $604,000
Q4 2020

Feb 16, 2021

BUY
$16.4 - $22.9 $287,328 - $401,208
17,520 Added 129.97%
31,000 $637,000
Q3 2020

Nov 13, 2020

BUY
$14.05 - $18.13 $189,394 - $244,392
13,480 New
13,480 $238,000

Others Institutions Holding PROF

About Profound Medical Corp.


  • Ticker PROF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,851,300
  • Market Cap $146M
  • Description
  • Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...
More about PROF
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.